Clinical Trial Update: Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the mitochondrial antioxidant MitoQ for lower urinary tract symptoms and overactive bladder in older women with metabolic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms
• Overactive Bladder

Drugs mentioned

• MitoQ

Snippet

Sponsor: Iman Al-Naggar, PhD | Conditions: Lower Urinary Tract Symptoms, Overactive Bladder Syndrome | Phase 2 | Status: RECRUITING